News

Sep 27
Jabil stock jumps after earnings beat, upbeat outlook and new $1 billion stock repurchase program

Shares of Jabil Inc. JBL, +1.19% jumped 5.1% in premarket trading Tuesday, after the contract manufacturer reported fiscal fourth-quarter earnings that beat expectations, provided an upbeat outlook for the current quarter and set a $1 billion stock buyback program. Net income for the quarter to Aug. 31 rose to $315 million, or $2.25 a share, […]

Sep 27
Coronavirus tally: Canada to scrap face-mask mandate on planes from Oct. 1

The Canadian government announced Monday it will no longer require people to wear masks on planes to guard against COVID, the Associated Press reported. The rules will be lifted October 1. Government officials also confirmed Canada is dropping the vaccine requirement for people entering the country at the end of the month. The news comes […]

Sep 27
Bankrupt crypto lender Celsius’s CEO resigns

Alex Mashinsky, chief executive at bankruptcy crypto lender Celsius, has submitted a letter of resignation from his post Tuesday, effective immediately. “I will continue to maintain my focus on working to help the community unite behind a plan that will provide the best outcome for all creditors – which is what I have been doing […]

Sep 27
Ichimoku Cloud Analysis 27.09.2022 (GBPUSD, USDCHF, AUDUSD)

GBPUSD, “Great Britain Pound vs US Dollar” GBPUSD is correcting after plummeting earlier. The instrument is currently moving below Ichimoku Cloud, thus indicating a descending tendency. The markets could indicate that the price may test Kijun-Sen at 1.0905 and then resume moving downwards to reach 1.0105. Another signal in favour of a further downtrend will […]

Sep 27
Japanese Candlesticks Analysis 27.09.2022 (USDCAD, AUDUSD, USDCHF)

USDCAD, “US Dollar vs Canadian Dollar” As we can see in the H4 chart, after forming a Shooting Star reversal pattern close to the resistance level, USDCAD may reverse in the form of a new descending wave. In this case, the downside correctional target may be at 1.3600. Later, the market may rebound from this […]

Sep 27
CRISPR, Vertex say FDA granted rolling review to experimental CRISPR therapy

CRISPR Therapeutics Inc. CRSP, +5.86% and Vertex Pharmaceuticals Inc. VRTX, +4.13% said Tuesday that the Food and Drug Administration granted a rolling review to the exagamglogene autotemcel, the therapy the companies are developing to treat sickle cell disease and transfusion-dependent beta thalassemia. CRISPR’s stock was up 3.1% in premarket trading on Tuesday, while Vertex shares […]